Nalagenetics

About:

Nalagenetics is a biotechnology company that provides genetic testing services.

Top Investors: The Agency for Science, Technology and Research, Google for Startups, East Ventures, Intudo Ventures, Vulcan Capital

Description:

Nalagenetics is a health-tech company that provides genetic testing. In 2016, the company collaborated with the Indonesian health ministry to distribute 1,000 genetic test kits in five villages in Papua and West Papua. The company's tests revealed that 20% of leprosy patients in the area carry the gene responsible for potentially fatal reactions to Dapsone, an anti-leprosy medication; this discovery assisted doctors in determining which patients could be safely treated with the antibiotic.

Total Funding Amount:

$13.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Singapore, Central Region, Singapore

Founded Date:

2016-01-01

Founders:

Alexander Lezhava, Astrid Irwanto, Jianjun Liu, Levana Sani

Number of Employees:

11-50

Last Funding Date:

2024-05-01

IPO Status:

Private

Industries: